Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Anti-CD73 antibody (Human IgG1) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human CD73 Protein, His Tag (Cat. No. CD3-H52H7) with an affinity constant of 0.164 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Anti-CD73 monoclonal antibody (Bristol-Myers Squibb) | Phase 1 Clinical | Neoplasms | Details | ||
BR-101 | BR101; BR-101 | Phase 1 Clinical | BioRay Pharmaceutical Co Ltd | Solid tumours | Details |
BMS-986179 | BMS-986179 | Bristol-Myers Squibb Company | Details | ||
LY-3475070 | LY-3475070 | Eli Lilly And Company | Details | ||
PM-1015 | PM1015; PM-1015 | Phase 1 Clinical | Biotheus Inc | Solid tumours | Details |
ORIC533 | ORIC-533 | Phase 1 Clinical | Oric Pharmaceuticals Inc | Multiple Myeloma; Neoplasm Metastasis | Details |
IPH-5301 | IPH-5301 | Phase 1 Clinical | Innate Pharma | Solid tumours; Ovarian Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Neoplasms; Breast Neoplasms; Lung Neoplasms; Endometrial Neoplasms; Neoplasm Metastasis | Details |
IBI-325 | IBI-325 | Phase 1 Clinical | Innovent Biologics(Suzhou) Co Ltd | Solid tumours | Details |
Mupadolimab | CPI-006 | Phase 2 Clinical | Corvus | Coronavirus Disease 2019 (COVID-19); Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Lymphoma, Non-Hodgkin; Endometrial Neoplasms; Colorectal Neoplasms; Prostatic Neoplasms; Sarcoma; Urinary Bladder Neoplasms; Head and Neck Neoplasms; Pancreatic Neoplasms; Triple Negative Breast Neoplasms; Papillomavirus Infections; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Solid tumours; Ovarian Neoplasms | Details |
JAB-BX102 | JAB-BX102 | Phase 2 Clinical | Jacobio Pharmaceuticals Co Ltd | Solid tumours | Details |
PT-199 | PT-199 | Phase 1 Clinical | Phanes Therapeutics Inc | Colonic Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Lung Neoplasms; Thyroid Neoplasms; Colorectal Neoplasms; Breast Neoplasms; Pancreatic Neoplasms; Head and Neck Neoplasms; Triple Negative Breast Neoplasms; Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Ovarian Neoplasms; Solid tumours | Details |
INCA-00186 | INCA-00186 | Phase 1 Clinical | Incyte Corp Ltd | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Gastrointestinal Neoplasms | Details |
CB-708 | CB-708; CB708; ATG-037 | Phase 1 Clinical | Calithera Biosciences Inc | Solid tumours; Neoplasms | Details |
SRF-373(Surface Oncology) | SRF-373; NZV-930 | Phase 1 Clinical | Surface Oncology Inc | Ovarian Neoplasms; Solid tumours; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Prostatic Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung | Details |
HLX-23 | HLX-23 | Phase 1 Clinical | Shanghai Henlius Biologics Co Ltd | Solid tumours | Details |
Quemliclustat | AB-680 | Phase 2 Clinical | Arcus Biosciences Inc, Gilead Sciences Inc | Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Colorectal Neoplasms | Details |
Dalutrafusp alfa | AGEN-1423; GS-1423 | Phase 2 Clinical | Gilead Inc, Agenus Inc | Solid tumours; Pancreatic Neoplasms; Neoplasms; Carcinoma, Pancreatic Ductal | Details |
Oleclumab | MEDI-9447 | Phase 3 Clinical | Medimmune Llc | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma; Carcinoma, Renal Cell; Hemangiosarcoma; Triple Negative Breast Neoplasms; Neoplasms; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Liposarcoma; Prostatic Neoplasms; Osteosarcoma; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung | Details |
Dresbuxelimab | AK-119 | Phase 2 Clinical | Akeso Pharmaceuticals Inc | Solid tumours; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Carcinoma, Non-Small-Cell Lung | Details |
Uliledlimab | TJ-004309; TJD-5; TJ-4309 | Phase 2 Clinical | I-Mab Biopharma Co Ltd | Solid tumours; Ovarian Neoplasms; Head and Neck Neoplasms; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Neoplasm Metastasis; Gastrointestinal Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.